Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

1 hr ago | BioSpace

Top 10 Fastest Growing Employers Outside Of Big Pharma

September 16, 2014 By Renee Morad , BioSpace.com Breaking News Staff A recent report published by EP Vantage reveals that many big pharma companies are slowly shrinking when it comes to employee headcount. At the other end of the spectrum, the number of employees at big biotech firms and specialty drug makers are rapidly growing - more than offsetting the loss of jobs in big pharma.

Comment?

Related Topix: Best of 2007, Startups, BioSpace.com, Biotech, Science / Technology, Medicine, Healthcare Industry, Bristol Myers Squibb, Novartis

6 hrs ago | Freshnews

Alnylam Strengthens Management Team with New Key Appointments

Alnylam Pharmaceuticals, Inc . , a leading RNAi therapeutics company, announced today the expansion of its management team with the appointments of Karen Anderson as Senior Vice President, Chief Human Resources Officer; Laurie Keating as Senior Vice President, General Counsel, and Secretary; and Marko Kozul, M.D., as Vice President, Strategy.

Comment?

Related Topix: Biotech, Medicine, Sirna Therapeutics, Healthcare Industry, Alnylam Pharmaceuticals, Biogen Idec, Bowling Green State University, Oncology

Mon Sep 15, 2014

SchaeffersResearch.com

Dow Jones Industrial Average Retakes 17,000; Momentum Names Get Creamed

The Dow Jones Industrial Average muscled back atop the 17,000 level today, paring some of its losses from last week ahead of the Federal Open Market Committee's two-day policy meeting , which begins tomorrow. The rest of the major market indexes weren't so lucky.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Microsoft, Startups, Opinion, Day Trading, Financial Markets, Personal Finance

AmericanBankingNews.com

Pfizer Sees Unusually High Options Volume

Pfizer was the recipient of some unusual options trading on Monday. Stock investors acquired 31,143 put options on the company, Stock Ratings Network reports.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Bloomberg

U.K. Merger Panel Seeks Tougher Rules on Job Promises

The U.K.'s takeover regulator has proposed giving itself powers to enforce commitments by buyers to retain jobs or factories in a merger. The Takeover Panel today published a consultation document on new rules, which it said were prompted by Pfizer Inc. 's attempted takeover of British drugmaker AstraZeneca Plc , which was rejected earlier this year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Investopedia

How Merck Found Its Way Into Millions Of Medicine Cabinets

Imagine a world where male pattern baldness is irreversible, human papillomavirus is inevitable, and a routine asthma attack could spell death. That'd be a world without Propecia, Gardasil and Singulair, which would mean no Whitehouse Station, N.J.-based Merck & Co.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, HPV, Health, Asthma, Singulair, Montelukast (generic), Novartis

Seeking Alpha

10 More Overvalued Shorts

Due to the wide readership of last week's 5 New Extremely Overvalued Shorts article , enclosed are 10 more overvalued shorts. In response to comments about the low liquidity in the five shorts mentioned last week, several of the following shorts have higher trading volume.

Comment?

Related Topix: Medicine, Biotech, Healthcare Industry, Healthcare Law, Law

American Reporter

Make My DayCATCH

The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose. Deep into a third decade as an investment professional gives me the poetic license to call the start of the next big, generational bull market, when the Dow Jones Industrial Average at this writing is down 232 points and a number of important technical support indicators have been shattered on the downside.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Microsoft, Startups, Biotech, Medicine, Healthcare Industry

Fri Sep 12, 2014

Reuters

UPDATE 1-Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor

Pfizer Inc and India's Ranbaxy Laboratories Ltd on Friday won dismissal of an antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor, the best-selling drug in history. U.S. District Judge Peter Sheridan in Trenton, New Jersey ruled that the plaintiffs, retailers and distribution companies that bought Lipitor directly from Pfizer, failed to plead their case with enough detail.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cholesterol, Health, Trenton, NJ

The Jersey Journal

Adult comedy and magic show Sept. 24 at Garwood Library

On Wednesday, Sept. 24, at 7 p.m.,, magician Mark Zacharia will present a comedy/magic show for adult audiences at the Garwood Public Library.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

TheStreet.com

Trading Guidelines for J&J, Merck, Pfizer, 8 Other Drug Companies

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Mozilla, TheStreet

Sys-Con Media

Study Results, New Collaboration, Drug Designation, Technical Update, ...

Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. , AbbVie Inc. , Pfizer Inc. , United Therapeutics Corporation and Brookdale Senior Living, Inc. . Private wealth members receive these notes ahead of publication.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

American Reporter

Make My DayCATCH

The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose. Deep into a third decade as an investment professional gives me the poetic license to call the start of the next big, generational bull market, when the Dow Jones Industrial Average at this writing is down 232 points and a number of important technical support indicators have been shattered on the downside.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Microsoft, Startups, Biotech, Medicine, Healthcare Industry

Thu Sep 11, 2014

BioSpace

Mergers Hamper Innovation, Ex-Pfizer Top Exec Says

NEW HAVEN>> A former executive in charge of research and development at Pfizer Inc. said consolidation within the pharmaceutical industry is hurting innovation. Dr. John LaMattina, former president of global research and development at Pfizer, said Wednesday that as the number of players in the industry shrinks, the amount of money devoted to research and development of new drugs also drops dramatically.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

The Motley Fool

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks tend to be strong performers over the long term due to their ability to harness the awesome power of compounding returns. Even so, investors should always bear in mind that not all dividend stocks are good investments, even when they are associated with a strong brand.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Cholesterol, Health, Oncology

Bloomberg

Magic Mushrooms' Help Smokers Kick Habit in Small Study

Just two or three experiences with "magic mushrooms" helped a dozen long-term smokers quit, succeeding in a study where numerous other approaches failed. The volunteers took a pill containing psilocybin, the active hallucinogenic ingredient in magic mushrooms, as part of a cognitive behavior therapy program at Johns Hopkins University in Baltimore.

Comment?

Related Topix: Drugs, Johns Hopkins University, Biotech, Medicine, Healthcare Industry, Nicotine, NicoDerm, Nicotine (generic)

Customer Interaction Solutions

BUYINS.NET: Market Maker Surveillance Report. PFE, BAC, GE, RAD, WFC, ...

BUYINS.NET: Market Maker Surveillance Report. PFE, BAC, GE, RAD, WFC, CSCO, Bullishly Biased Price Friction For Wednesday, September 10th 2014 BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Banking, Bank of America, Financial Services, Retail, Rite Aid, Wells Fargo , Startups, Cisco Systems, 9

Wed Sep 10, 2014

Hispanic Business

eResearch Highlights NYSE Volume Leaders for September 9

For Petroleo Brasileiro S/A ADS Rite Aid Corp. Ford Motor Co. Twitter Inc. Vale S.A. ADS General Electric Co.

Comment?

Related Topix: Biotech, Medicine, North American Scientific, Medical Equipment, Healthcare Industry, Automakers, Ford Motor, Twitter, Boston Scientific, Sprint Nextel, Telecom, IT Services

BioSpace

Dad-Turned-CEO Of Inks Duchenne Drug Development Pact With Pfizer Inc.

A Cambridge biotech firm headed by a father with a quest to find a treatment for Duchenne muscular dystrophy is working with drug giant Pfizer to test one of its early-stage experimental drugs. Solid Ventures, headed by former JP Morgan fund manager and Newton resident Ilan Ganot, disclosed the deal a few weeks ago on a new, redesigned website but didn't issue a formal announcement, said Joel Schneider, scientific analyst at the company.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Tue Sep 09, 2014

Seeking Alpha

Riding Merck: The Conservative Aggressive Pharmaceutical Stock Of The Year

Merck is conservative because it's a blue chip that pays an annual dividend of 3.1% and has a diversified portfolio. Merck is an aggressive play with 20%-30% upside based on its potential for an all-oral Hepatitis C combo regimen and its new immuno-oncology drug, Keytruda.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Oncology, GlaxoSmithKline, Novartis

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••